OVERVIEW

An Evidence-based, Individualized Approach to the Management of Gastrointestinal Malignancies is organized by Med Learning Group.

Dates:
Release Date: August 06, 2019
Expiration Date: August 06, 2020

Accreditation:
Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 2.0 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Nursing Credit Information
Purpose:
This program would be beneficial for nurses involved in the treatment and management of patients with gastrointestinal cancers.
CNE Credits:
2.0 ANCC Contact Hour(s).

CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.

Description:
This case-based online activity will cover the treatment and management of patients with gastrointestinal cancers.

Objectives:
After completing the CME activity, learners should be better able to:
• Review evidence and guideline recommendations for optimal sequencing of different treatment modalities across subsequent lines of therapy for advanced and metastatic gastric and (GC) and gastroesophageal junction (GEJ) cancers
• Discuss strategies to individualize therapy for advanced and metastatic GC and GEJ cancers based on patient’s characteristics and biomarkers across lines of treatment
• Review the clinical evidence of the prognostic and predictive value of anatomical characteristics and biomarkers profiling in guiding treatment selection for advanced and metastatic colorectal cancer (CRC) across lines of therapy
• Review the biology of α-fetoprotein (AFP) in hepatocellular carcinoma (HCC) carcinogenesis; explain the clinical significance of elevated serum AFP; and discuss AFP’s role as a prognostic and predictive biomarker in HCC